Literature DB >> 23228395

Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression.

Aifen Lin1, Hui-Hui Xu, Dan-Ping Xu, Xia Zhang, Qing Wang, Wei-Hua Yan.   

Abstract

Previous study showed that aberrant HLA-G expression in cancer cells plays important roles in disease progression and it was associated with tumor metastasis and with poor survival in an animal model with ovarian cancer; however, the mechanisms remain to be explored. In this study, we found that HLA-G expression could dramatically decreased the NK cytotoxicity against the ovarian carcinoma cell line (HO-8910) engineered to express HLA-G (HO-8910-G), and matrix metalloproteinase-15 (MMP-15) expression was up-regulated in HO-8910-G cells. Consistent with this, a strong correlation between HLA-G and MMP-15 expression were observed in a cohort of ovarian cancer samples. Knockdown the HLA-G induced MMP-15 expression by small interfere RNA (siRNA) significantly decreased the HO-8910-G cell migration potential and tumor metastasis. Collectively, our study indicated that HLA-G involved in tumor invasiveness or metastasis may rely on the NK cytotoxicity inhibition and induction of MMP-15 expression in ovarian cancer.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23228395     DOI: 10.1016/j.humimm.2012.11.021

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  20 in total

1.  Proteomic analysis of knock-down HLA-G in invasion of human trophoblast cell line JEG-3.

Authors:  Haiyan Liu; Xueyuan Liu; Hong Jin; Fengying Yang; Weirong Gu; Xiaotian Li
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

2.  Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

Review 3.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

4.  HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas.

Authors:  M J Rutten; F Dijk; C D Savci-Heijink; M R Buist; G G Kenter; M J van de Vijver; E S Jordanova
Journal:  J Immunol Res       Date:  2014-05-27       Impact factor: 4.818

Review 5.  A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.

Authors:  Antonino Bruno; Guido Ferlazzo; Adriana Albini; Douglas M Noonan
Journal:  J Natl Cancer Inst       Date:  2014-09-01       Impact factor: 13.506

6.  Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.

Authors:  Danli Wu; Isere Kuiaste; Philippe Moreau; Edgardo Carosella; Patricia Yotnda
Journal:  Oncotarget       Date:  2015-11-10

7.  Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.

Authors:  Hui-Hui Xu; Jun Gan; Dan-Ping Xu; Lu Li; Wei-Hua Yan
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

8.  Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.

Authors:  Brittany Anne Davidson; Jennifer M Rubatt; David L Corcoran; Deanna K Teoh; Marcus Q Bernardini; Lisa A Grace; William John Soper; Andrew Berchuck; Sharareh Siamakpour-Reihani; Wei Chen; Kouros Owzar; Susan K Murphy; Angeles Alvarez Secord
Journal:  Front Oncol       Date:  2014-06-20       Impact factor: 6.244

9.  The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology.

Authors:  Vera Rebmann; Lisa König; Fabiola da Silva Nardi; Bettina Wagner; Luis Felipe Santos Manvailer; Peter A Horn
Journal:  Front Immunol       Date:  2016-05-04       Impact factor: 7.561

Review 10.  HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.